June 27, 2003
Ver artículo completoIs it time to measure microalbuminuria in hypertension?
Resultado clave
Measuring microalbuminuria in hypertensive patients supports the prediction of absolute cardiovascular risk and guides the initial choice of antihypertensive treatment.
PICO estructurado
Does measuring microalbuminuria improve cardiovascular risk prediction and treatment selection in hypertensive patients?
P
Población
Hypertensive patients
I
Intervención
Measurement of microalbuminuria
Microalbuminuria measurement is advocated for risk stratification and guiding initial antihypertensive treatment in hypertensive patients, challenging former guidelines.
Resumen
Former guidelines on hypertension never made a commitment to the detection of microalbuminuria for screening or follow-up of hypertensive patients. On the other hand, growing evidence support the contributory role of microalbuminuria in the prediction of absolute cardiovascular risk in hypertension and document the potential relevance of this parameter to the initial choice of antihypertensive treatment. Upcoming new guidelines and diagnostic algorithms in hypertension need to underscore the clinical positioning of microalbuminuria for stratification of risk and follow-up purposes.